Clinical Trials Browser

Phase EARLY_PHASE1 × Uterine Neoplasms × Clear all

Uterine Neoplasms, Endometrial Neoplasms, Cystadenocarcinoma, Serous

NCT03694834 2023-11-28

Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer

Phase EARLY_PHASE1 Terminated

3 enrolled

Gynecologic

Uterine Neoplasms, Endometrial Neoplasms

NCT02646319 2019-06-06

Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations

Phase EARLY_PHASE1 Completed

2 enrolled

BreastGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Recurrence, Uterine Neoplasms, Endometrial Neoplasms

Clinical Trials

NIREC

Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer

Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations